Condition: Adenocarcinoma · Carcinoma · Neoplasms · Sponsor: University Hospital, Toulouse
BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in order to support future research projects.
This description comes directly from the study's public registry record.
Barbara BOURNET, MD, PhD · (0)5 61 32 32 35 · bournet.b@chu-toulouse.fr
Cindy CANIVET, PhD · (0)5 61 32 20 48 · canivet.c@chu-toulouse.fr
Always discuss trial participation with your own doctor first.
| Béthune hospital center | Béthune, France | Not Yet Recruiting |
| Haut-Lévêque Hospital | Bordeaux, France | Not Yet Recruiting |
| Huriez Hospital | Lille, France | Not Yet Recruiting |
| Jean Mermoz private hosptila | Lyon, France | Not Yet Recruiting |
| Saint Eloi Hospital | Montpellier, France | Not Yet Recruiting |
| Regional Cancer Center From Montpellier | Montpellier, France | Not Yet Recruiting |
| PAU hospital | Pau, France | Not Yet Recruiting |
| Rangueil hospital | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06128343